Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes

OBJECTIVE: As gene-based therapies may soon arise for patients with spinocerebellar ataxia (SCA), there is a critical need to identify biomarkers of disease progression with effect sizes greater than clinical scores, enabling trials with smaller sample sizes. METHODS: We enrolled a unique cohort of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuroimage Clin
Prif Awduron: Adanyeguh, Isaac M., Perlbarg, Vincent, Henry, Pierre-Gilles, Rinaldi, Daisy, Petit, Elodie, Valabregue, Romain, Brice, Alexis, Durr, Alexandra, Mochel, Fanny
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2018
Pynciau:
Regular Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6005808/
https://ncbi.nlm.nih.gov/pubmed/29922574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2018.06.011
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg